ABBV - AbbVie Corp. Market Capitalization

This price chart for AbbVie Inc. (ABBV) reflects the performance of a company whose efficiency relies on the flawless transportation of biologics and the reliability of cold chains, with a market capitalization of 521.88. Stable cash flow is driven by inelastic demand for oncology and immunology therapies, although patent expiration risks necessitate active M&A deals. The business is virtually immune to external political shocks, operating primarily within the framework of legal regulation.

ABBV (AbbVie) Market Value history from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for AbbVie Corp. (ABBV)

- current price and projected stock value:

Stock Price AbbVie|ABBV - Price Target Chart

- market capitalization statistics:

Market Capitalization AbbVie Corp.|ABBV - Total Company Value

- issuer book value statistics:

Accounting Value per Share AbbVie|ABBV - Company Book Value|Market Value to Book Value Ratio abbvie.com|ABBV - Total Asset Value of Company

- business debt structure and liquidity details:

- net income and valuation multiples indicators:

ABBV - Net Profit|Future Profit AbbVie Inc.|ABBV - Company Value to Net Income|Forward P/E Multiple Abbvie|ABBV - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AbbVie Corp.|ABBV - Profit before interest, taxes and amortization|Earnings per share for the last twelve months AbbVie|ABBV - Earnings per share for the last twelve months|Quarterly EPS earnings growth abbvie.com|ABBV - Earnings per share growth this year|Earnings growth forecast for next year AbbVie Inc.

- sales revenue and business income indicators:

ABBV - Company Gross Revenue|Company Projected Revenue AbbVie|ABBV - Market Cap to Revenue Ratio|Forward P/S Multiple AbbVie Corp.

Fundamental company analysis:ABBV (AbbVie)

AbbVie Inc. maintains a flawless logistics network and global site diversification that ensure stable operational flows, which is directly reflected in the dynamics of the issuer's market capitalization. This indicator is calculated as the product of the current share price and the total number of outstanding shares, measuring the aggregate market value of the business and allowing investors to assess capital resilience through the lens of market demand.

Key competitors